Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Pregnenolone 50 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer. This design ensures a gradual release of the hormone pregnenolone over an extended period, offering sustained therapeutic effects. These capsules are beneficial in managing conditions such as depression, adrenal fatigue, menopause, anxiety, and fibromyalgia by providing a steady dose of the hormone. The reduced dosing frequency improves patient compliance, especially for medications requiring a controlled and prolonged release profile.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Pregnenolone 50 mg Slow Release Capsules is a specially compounded medication designed to treat a variety of disease states. This formulation is uniquely designed to provide a slow, sustained release of the active ingredient, pregnenolone, over an extended period of time. The slow release mechanism is achieved through the use of Methocel E4M, a type of controlled-release polymer. This innovative formulation technique allows for a more consistent and sustained release of the medication, thereby offering enhanced therapeutic effects.
Pregnenolone is a hormone that is naturally produced in the body and plays a crucial role in various physiological processes, including the production of other hormones. It is used in the treatment of a range of conditions such as adrenal insufficiency, depression, anxiety, and fatigue. Additionally, pregnenolone can be used to improve cognitive function and memory, as well as to reduce inflammation.
The slow release formulation of Pregnenolone 50 mg Slow Release Capsules ensures a more consistent and sustained release of the medication. This formulation is designed to provide a slow release of the active ingredient, pregnenolone, over a period of time. This slow release allows for a more consistent and sustained release of the medication.
This formulation is designed to provide a slow release of the active ingredient, pregnenolone, over a period of time. This slow release allows for a more consistent and sustained release of the medication.
If you have any questions about Pregnenolone 50 mg Slow Release Capsules or any other compounded medications, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to assist you with any queries you may have.
Pregnenolone 50 mg Slow Release Capsules are a compounded formulation designed to gradually release the active ingredient over an extended period of time. This is achieved through the use of Methocel E4M, a controlled-release polymer. The slow release of the medication offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications that require a controlled and prolonged release profile.
It's important to be aware that Pregnenolone 50 mg Slow Release Capsules may interact with certain medications, including anticoagulants, anticonvulsants, and corticosteroids. Additionally, interactions may occur with certain supplements such as St. John's wort, ginseng, and omega-3 fatty acids. Therefore, patients should inform their healthcare provider of any medications or supplements they are currently taking prior to starting this medication.
Pregnenolone 50 mg Slow Release Capsules may be used to treat a variety of conditions, including adrenal insufficiency, menopause, and premenstrual syndrome. It may also be beneficial in treating depression, anxiety, and fatigue. Symptoms associated with these conditions, such as hot flashes, mood swings, and insomnia, may be reduced with the use of this medication.
However, it is crucial to understand that Pregnenolone 50 mg Slow Release Capsules should not be used as a substitute for conventional medical treatment. Always consult with a healthcare provider before starting any new medication or supplement.
If you have any questions about Pregnenolone 50 mg Slow Release Capsules or its potential interactions, please consult with your healthcare provider or pharmacist.
Pregnenolone 50 mg Slow Release Capsules are a hormone supplement designed to treat a variety of conditions such as adrenal fatigue, menopause, and premenstrual syndrome. The capsules are formulated with Methocel E4M, a type of controlled-release polymer, which allows for a gradual and extended release of the hormone into the body. This slow release formulation provides a more consistent level of hormone throughout the day, reducing the risk of side effects associated with sudden spikes in hormone levels.
Notably, Pregnenolone is known to help improve mood, energy levels, and cognitive function. The slow release of this hormone supplement offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
When taking Pregnenolone 50 mg Slow Release Capsules, it is crucial to adhere to the instructions provided by your healthcare provider. The capsules should be taken once daily, preferably with food, and at the same time each day to ensure consistent hormone levels. It is also important to avoid exceeding the recommended dose, as this can lead to serious side effects.
If you have any questions or concerns about Pregnenolone 50 mg Slow Release Capsules, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to assist you with any queries you may have.
Pregnenolone 50 mg Slow Release Capsules are a compounded formulation designed to gradually release the active ingredient over an extended period of time. This is achieved through the use of Methocel E4M, a controlled-release polymer. The slow release of Pregnenolone offers sustained therapeutic effects, reduces the need for frequent dosing, and improves patient compliance, particularly for medications requiring a controlled and prolonged release profile.
These capsules may be used to treat a variety of conditions. Studies have also indicated that Pregnenolone can improve mood, reduce stress, and increase energy levels. It may also be beneficial in improving sleep quality, reducing inflammation, and enhancing skin health.
Further research has suggested that Pregnenolone may have potential in improving athletic performance, reducing the risk of cardiovascular disease, and lowering the risk of certain types of cancer. It may also be used to alleviate the symptoms of premenstrual syndrome and to improve fertility in women.
While Pregnenolone is generally well tolerated, it is crucial to discuss any potential side effects with your healthcare provider before starting treatment. If you have any questions about using Pregnenolone 50 mg Slow Release Capsules for any of these conditions, please consult with your healthcare provider.
Pregnenolone 50 mg Slow Release Capsules is a medication that is encapsulated in a controlled-release polymer, Methocel E4M. This formulation is designed to gradually release the active ingredient over an extended period of time.
The controlled-release polymer, Methocel E4M, is designed to release the medication gradually over an extended period of time. This offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance for medications requiring a controlled and prolonged release profile.
A slow release formulation offers several benefits. It provides sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance. This is particularly beneficial for medications that require a controlled and prolonged release profile.
As this is a slow release formulation, the frequency of dosing is typically reduced. However, the exact dosing schedule should be determined by your healthcare provider based on your specific medical condition and response to therapy.
Methocel E4M is a type of controlled-release polymer. It is used in the formulation of certain medications to ensure that the active ingredient is released gradually over an extended period of time.
No, the slow release formulation does not affect the effectiveness of the medication. In fact, it enhances the therapeutic effects by ensuring a steady release of the active ingredient over a prolonged period.
No, the capsule should not be opened, crushed, or chewed. Doing so can release all of the drug at once, increasing the risk of side effects. The capsule should be swallowed whole.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Take your next dose at the regular time. Do not double the dose to catch up.
Yes, this medication can be taken with or without food. However, it is important to take this medication consistently, either always with food or always on an empty stomach, as directed by your healthcare provider.
If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call emergency services immediately. Otherwise, call a poison control center right away.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
